Supplementary Table 1 from Validation of the p21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2
Open Access
- 30 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Supplementary Table 1 from Validation of the p21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2Keywords
This publication has 0 references indexed in Scilit: